PCRX PharmaCorp Rx Inc.
PharmaCorp Rx Inc. operates retail pharmacies under the PharmaChoice name in Canada. The company offers prescription services; front-of-store retail, such as convenience goods, over-the-counter medications, health products, and wellness items; custom compounding; specialized consultations; and lifestyle programs. PharmaCorp Rx Inc. was incorporated in 2021 and is headquartered in Saskatoon, Canada.…
Industry Peers
Pharmaceutical RetailersKey Statistics
About PharmaCorp Rx (CVE: PCRX)
›
PharmaCorp Rx (CVE: PCRX) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Pharmaceutical Retailers industry, part of the Healthcare sector, and reports about 5 employees.
The shares were at 0.4050 CAD on 19 November 2026, down 4.7% over 52 weeks. Its 52-week range is 0.3750 CAD to 0.5800 CAD: the price is 30.2% below the high and 8.0% above the low.
Its market capitalisation is 79.78M CAD.
PharmaCorp Rx reports return on equity of -2.7%, an operating margin of -4.8% and revenue up 75.8% year over year.
It holds more cash than debt, a net cash position of 19.59M CAD. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 3 analysts cover the stock; their mean price target of 0.6667 CAD is 64.6% above the current price. The next earnings report is expected on 3 December 2026.